Search Results - "Matuska, Jiri"
-
1
Sulodexide for the Symptoms and Signs of Chronic Venous Disease: A Systematic Review and Meta-analysis
Published in Advances in therapy (01-03-2020)“…Introduction Chronic venous disease (CVD) is a common condition associated with valvular dysfunction, venous hypertension and endothelial inflammation…”
Get full text
Journal Article -
2
Sulodexide for Diabetic-Induced Disabilities: A Systematic Review and Meta-Analysis
Published in Advances in therapy (01-03-2021)“…Introduction Micro- and macrovascular complications of diabetes are leading morbidities in the world population. They are responsible not only for increased…”
Get full text
Journal Article -
3
Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Published in Circulation (New York, N.Y.) (17-11-2015)“…Patients with a first episode of unprovoked venous thromboembolism have a high risk of recurrence after discontinuation of anticoagulant therapy. Extending…”
Get full text
Journal Article -
4
Stimulation TcPO2 Testing Improves Diagnosis of Peripheral Arterial Disease in Patients With Diabetic Foot
Published in Frontiers in endocrinology (Lausanne) (10-12-2021)“…All diagnostic procedures of peripheral arterial disease (PAD) in diabetic foot (DF) are complicated due to diabetes mellitus and its late complications.The…”
Get full text
Journal Article -
5
Recurrences and bleeding during extended treatment of patients with venous thromboembolism: results of the international, prospective, observational WHITE study
Published in International angiology (01-02-2023)“…Little data are available on real-life long-term treatments after a venous thromboembolism (VTE), and on recurrent VTE or bleeds events during treatments. We…”
Get more information
Journal Article -
6
Influence of clinical presentation, site, and extent of venous thrombosis on decision about duration of anticoagulation: Data from the international, prospective, observational WHITE study
Published in Thrombosis research (01-03-2022)“…Low attention has generally been dedicated to the influence of clinical presentation, extent of venous thrombosis and presence of residual vein obstruction…”
Get full text
Journal Article -
7
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Summary of the document prepared by the Czech Society of Cardiology and the Czech Society of Angiology
Published in Cor et vasa (English ed.) (01-04-2018)Get full text
Journal Article -
8
Unprovoked or provoked venous thromboembolism: not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries—the prospective, international, observational WHITE study
Published in Internal and emergency medicine (01-01-2022)“…The decision on treatment after a first venous thromboembolism (VTE) to prevent recurrences may be influenced by many factors. The prospective, observational,…”
Get full text
Journal Article -
9
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine
Published in Thrombosis and haemostasis (01-12-2020)“…COVID-19 is also manifested with hypercoagulability, pulmonary intravascular coagulation, microangiopathy, and venous thromboembolism (VTE) or arterial…”
Get more information
Journal Article -
10
Anticoagulation Duration After First Venous Thromboembolism: Real-Life Data From the International, Observational WHITE Study
Published in Clinical and applied thrombosis/hemostasis (01-11-2021)“…Background International guidelines recommend at least three months anticoagulation in all patients after acute venous thromboembolism (VTE) and suggest those…”
Get full text
Journal Article -
11